title: Recent technological advances in using mouse models to study ovarian cancer.
abstract: Serous epithelial ovarian cancer (SEOC) is the most lethal gynecological cancer in the United States with disease recurrence being the major cause of morbidity and mortality. Despite recent advances in our understanding of the molecular mechanisms responsible for the development of SEOC, the survival rate for women with this disease has remained relatively unchanged in the last two decades. Preclinical mouse models of ovarian cancer, including xenograft, syngeneic, and genetically engineered mice, have been developed to provide a mechanism for studying the development and progression of SEOC. Such models strive to increase our understanding of the etiology and dissemination of ovarian cancer in order to overcome barriers to early detection and resistance to standard chemotherapy. Although there is not a single model that is most suitable for studying ovarian cancer, improvements have led to current models that more closely mimic human disease in their genotype and phenotype. Other advances in the field, such as live animal imaging techniques, allow effective monitoring of the microenvironment and therapeutic efficacy. New and improved preclinical mouse models, combined with technological advances to study such models, will undoubtedly render success of future human clinical trials for patients with SEOC.
authors.affiliation: Women's Malignancies Branch, National Cancer Institute , Bethesda, MD , USA.
authors.forename: Carrie Danielle
authors.initials: CD
authors.lastname: House
authors.affiliation: Women's Malignancies Branch, National Cancer Institute , Bethesda, MD , USA.
authors.forename: Lidia
authors.initials: L
authors.lastname: Hernandez
authors.affiliation: Women's Malignancies Branch, National Cancer Institute , Bethesda, MD , USA.
authors.forename: Christina Messineo
authors.initials: CM
authors.lastname: Annunziata
keywords: cancer stem cells; imaging techniques; immune therapy; metabolite profiling; mouse models; reporter; serous epithelial ovarian cancer